To explore the role of gasdermin D (GSDMD)-induced pyroptosis in sepsis and its implications for therapeutic interventions.
Key Findings:
Connect elevated pyroptosis markers to clinical outcomes.
Interpretation:
The findings underscore the importance of targeting GSDMD and pyroptosis in sepsis treatment strategies to mitigate organ damage and improve survival rates.
Limitations:
Expand on the complexity of phase-adapted interventions.
Conclusion:
Targeting GSDMD and understanding pyroptosis mechanisms could lead to novel therapeutic strategies in sepsis management, warranting further research and clinical trials.
